Home > Healthcare > Medical Devices > Therapeutic Devices > Ablation Devices Market

Ablation Devices Market Analysis

  • Report ID: GMI3419
  • Published Date: Mar 2023
  • Report Format: PDF

Ablation Devices Market Analysis

Ablation devices market share from the radiofrequency devices segment is primed to grow at over 8.5% CAGR between 2023 and 2032. Radiofrequency devices find widespread usage in the field of oncology, cardiology, cosmetology, gynecology, and pain management. The growing prominence of cardiovascular diseases, primarily atrial fibrillation, has boosted the demand for radiofrequency devices. The high success rate of procedures with the use of radiofrequency devices in the treatment of atrial fibrillation has increased the product adoption rate, which will favor segment outlook.
 

Ablation devices market size from the cardiology segment was valued at over USD 3.5 billion in 2022 and is foreseen to grow at more than 9% CAGR during 2023-2032. The growing patient population suffering from severe heart-related disorders such as atrial fibrillation and tachycardia, among others, will enhance the segment growth potential with procedural demand. For instance, according to the Centers for Disease Prevention and Control, around 6.5 million people die due to cardiac conditions every year in the U.S.

 

Hospitals are likely to emerge as one of the promising end-users of ablation devices, with the segment poised to attain a valuation of USD 11.3 billion by 2032. The incidence rate of ablation procedures is considerably high in hospital settings as these establishments ensure the availability of skilled healthcare professionals and advanced equipment, reducing the complexity of the procedure. Additionally, innovative product launches in the ablation industry and extending government support toward improving the hospital infrastructure will aid segment share.
 

Global Ablation Devices Market Size, By Region

North America ablation devices market is set to witness over 9% CAGR through 2032. Increasing adoption of cutting-edge technologies, coupled with the presence of the most highly developed countries providing state-of-the-art facilities for conducting minimally invasive cardiac procedures, will influence regional landscape. Moreover, the high disposable incomes and increasing healthcare expenditure are also some of the factors supporting the market expansion in the region.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for ablation devices was worth more than USD 8.6 billion in 2022 and is estimated to expand at over 9% CAGR between 2023 and 2032, given the remarkable growth in the burden of chronic diseases worldwide.

Radiofrequency devices segment is set to exhibit over 8.5% CAGR from 2023 to 2032, attributed to the widespread utilization of radiofrequency devices in a variety of healthcare applications, including oncology, cardiology, cosmetology, gynecology, and pain management.

Hospitals segment of the ablation devices market is primed to garner USD 11.3 billion in revenue by 2032, owing to the high incidence rate of ablation procedures taking place across these establishments.

Major companies in the ablation devices industry are Abbott Laboratories, AngioDynamics, Atricure Inc., Alcon Laboratories, Bausch & Lomb Incorporated, Biotronik SE & Co. KG, CONMED Corporation, Elekta AB., Olympus Corporation, Varian, Ethicon, Inc (Johnson & Johnson), Medtronic plc, Boston Scientific Corporation, and others.

Ablation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 285
  • Countries covered: 27
  • Pages: 195
 Download Free Sample